盈峯環境(000967.SZ):中標兩個項目 中標總額預計約5.3億元
格隆匯9月23日丨盈峯環境(000967.SZ)公佈,近日,公司全資子公司長沙中聯重科環境產業有限公司(“公司”)收到兩個項目中標合作通知,項目一為公司作為聯合體牽頭方中標高明區中心城區核心區園林環衞服務項目(2021-2026 年度)一標段,中標總額預計為49253.81萬元;項目二為順德陳村生活垃圾中轉站改造工程設備採購項目,中標總額為3761萬元。上述兩個項目中標總額預計53014.81萬元。
公司中標上述項目,將增強公司環衞裝備及環衞一體化服務業務的市場影響力,進一步鞏固了公司在環衞裝備領域及環衞一體化服務領域的綜合競爭能力,對公司未來經營業績將產生積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.